1. Home
  2. CYCC vs SNES Comparison

CYCC vs SNES Comparison

Compare CYCC & SNES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYCC
  • SNES
  • Stock Information
  • Founded
  • CYCC 1992
  • SNES 2004
  • Country
  • CYCC United States
  • SNES United States
  • Employees
  • CYCC 12
  • SNES N/A
  • Industry
  • CYCC Biotechnology: Pharmaceutical Preparations
  • SNES Agricultural Chemicals
  • Sector
  • CYCC Health Care
  • SNES Industrials
  • Exchange
  • CYCC Nasdaq
  • SNES Nasdaq
  • Market Cap
  • CYCC 2.2M
  • SNES 2.3M
  • IPO Year
  • CYCC N/A
  • SNES 2016
  • Fundamental
  • Price
  • CYCC $0.36
  • SNES $2.80
  • Analyst Decision
  • CYCC Strong Buy
  • SNES Strong Buy
  • Analyst Count
  • CYCC 1
  • SNES 1
  • Target Price
  • CYCC $11.00
  • SNES $10.00
  • AVG Volume (30 Days)
  • CYCC 6.4M
  • SNES 50.7K
  • Earning Date
  • CYCC 11-12-2024
  • SNES 02-19-2025
  • Dividend Yield
  • CYCC N/A
  • SNES N/A
  • EPS Growth
  • CYCC N/A
  • SNES N/A
  • EPS
  • CYCC N/A
  • SNES N/A
  • Revenue
  • CYCC $74,000.00
  • SNES $1,651,000.00
  • Revenue This Year
  • CYCC N/A
  • SNES $76.36
  • Revenue Next Year
  • CYCC $88.68
  • SNES $103.47
  • P/E Ratio
  • CYCC N/A
  • SNES N/A
  • Revenue Growth
  • CYCC N/A
  • SNES 38.16
  • 52 Week Low
  • CYCC $0.31
  • SNES $1.90
  • 52 Week High
  • CYCC $4.00
  • SNES $13.30
  • Technical
  • Relative Strength Index (RSI)
  • CYCC 43.22
  • SNES 44.04
  • Support Level
  • CYCC $0.34
  • SNES $2.97
  • Resistance Level
  • CYCC $0.39
  • SNES $3.20
  • Average True Range (ATR)
  • CYCC 0.08
  • SNES 0.29
  • MACD
  • CYCC 0.00
  • SNES -0.07
  • Stochastic Oscillator
  • CYCC 6.30
  • SNES 9.99

About CYCC Cyclacel Pharmaceuticals Inc.

Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors, and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib, Sapacitabine, and plogosertib.

About SNES SenesTech Inc.

SenesTech Inc is a United States-based biotech platform and research company engaged in developing technology for managing animal pest populations through fertility control. The company provides its solutions to the animal market, commercial markets, and food markets. It currently has two product lines of fertility control products: ContraPest and Evolve.

Share on Social Networks: